Yi-An Ko

Title: Yi-An Ko: Innovator in Chimeric Influenza Vaccines

Introduction

Yi-An Ko is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of vaccine development, particularly focusing on chimeric influenza vaccines. With a total of three patents to his name, his work is paving the way for advancements in immunology and public health.

Latest Patents

Yi-An Ko's latest patents revolve around chimeric influenza virus hemagglutinin (HA) polypeptides. These patents describe a novel approach that includes one or more stem domain sequences, each exhibiting at least 60% homology with a stem domain consensus sequence of H1 subtype HA or H5 subtype HA. Additionally, these polypeptides are fused with one or more globular head domain sequences, also showing at least 60% homology with the corresponding consensus sequences. This innovative design aims to enhance the efficacy of influenza vaccines.

Career Highlights

Yi-An Ko is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on vaccine development and public health strategies. His dedication to research and innovation has positioned him as a key figure in the field.

Collaborations

Yi-An Ko collaborates with notable colleagues, including Hsin-Yu Liao and Shih-Chi Wang. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in vaccine innovation.

Conclusion

Yi-An Ko's contributions to the development of chimeric influenza vaccines highlight his role as an influential inventor in the field of immunology. His innovative approaches and collaborations are essential for advancing vaccine technology and improving public health outcomes.